Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms
Abstract
Key Points A preclinical model system was developed to define the molecular landscape dictating lymphoma resistance to immunotherapy. This system revealed that Gal-1 significantly inhibits CD20 immunotherapy within the lymphoma microenvironment in...
Paper Details
Title
Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms
Published Date
Apr 14, 2016
Journal
Volume
127
Issue
15
Pages
1886 - 1895
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History